Clinical Trial Update: Scorpio NRG (eNeRGize) Cruciate Retaining (CR) Post-market International Outcome Study [NA]

View source ↗

Summary

A completed post-market international outcome study for the Scorpio NRG Cruciate Retaining knee implant (eNeRGize) with results posted in 2021.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Arthroplasty Knee
• Knee Replacement

Drugs mentioned

• Scorpio NRG (eNeRGize) Cruciate Retaining (Cruciate Retaining knee implant system)

Snippet

Sponsor: Stryker Orthopaedics | Conditions: Arthroplasty, Replacement, Knee | NA | Status: COMPLETED | Results posted: 2021-06-14